636 related articles for article (PubMed ID: 19709328)
1. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
Sweileh WM
Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
[TBL] [Abstract][Full Text] [Related]
2. [Gentamicin and amikacin nephrotoxicity: comparative study in patients with initially normal renal function].
Ballesteros J; Northland R; Wolff M
Rev Med Chil; 1989 Jan; 117(1):10-7. PubMed ID: 2641618
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study.
Sweileh WM
Curr Clin Pharmacol; 2009 Sep; 4(3):229-32. PubMed ID: 19500072
[TBL] [Abstract][Full Text] [Related]
4. Proximal tubule damage in patients treated with gentamicin or amikacin.
Wiland P; Szechciński J
Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity induced by gentamicin and amikacin.
Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of amikacin nephrotoxicity in the hematology/oncology population.
Kiel PJ; Lo M; Stockwell D; Patel GP
Am J Ther; 2008; 15(2):131-6. PubMed ID: 18356633
[TBL] [Abstract][Full Text] [Related]
7. An overview of the safety of isepamicin in adults.
Blum D
J Chemother; 1995 Jun; 7 Suppl 2():87-93. PubMed ID: 8622116
[TBL] [Abstract][Full Text] [Related]
8. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
Karachalios GN; Houpas P; Tziviskou E; Papalimneou V; Georgiou A; Karachaliou I; Halkiadaki D
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):561-4. PubMed ID: 9799062
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
Rodriguez-Noriega E; Esparza-Ahumada S; Morfin-Otero R
J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
[TBL] [Abstract][Full Text] [Related]
11. Low serum albumin and the increased risk of amikacin nephrotoxicity.
Contreras AM; Ramírez M; Cueva L; Alvarez S; de Loza R; Gamba G
Rev Invest Clin; 1994; 46(1):37-43. PubMed ID: 8079062
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Covi M; Velluti G
J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
[TBL] [Abstract][Full Text] [Related]
13. Once daily isepamicin treatment in complicated urinary tract infections.
Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Colardyn F
J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
[TBL] [Abstract][Full Text] [Related]
17. [Dosing aminoglycosides once a day].
Blaser J
Schweiz Med Wochenschr Suppl; 1996; 76():39S-48S. PubMed ID: 8677418
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of single daily dose gentamicin in stem cell transplantation.
Warkentin D; Ippoliti C; Bruton J; Van Besien K; Champlin R
Bone Marrow Transplant; 1999 Jul; 24(1):57-61. PubMed ID: 10435736
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J
Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853
[TBL] [Abstract][Full Text] [Related]
20. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Herbrecht R; Blaise D; Espinouse D; Leblond V; Sadoun A; Sauvage C; Cordonnier C; Minozzi C
J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
